Nitrous Oxide for PTSD (N2OP)
Nitrous Oxide for Posttraumatic Stress Disorder (PTSD): A Phase IIa Trial
Sponsor: VA Office of Research and Development
Terminated
Use of VA hospital research space is indefinitely delayed due to prioritization of clinical cases delayed by COVID
Other terminated trials from VA Office of Research and Development
- SCI · Phase EARLY_PHASE1 · Feb 2026
- Spinal Cord Injury · Phase NA · Dec 2025
- Anxiety Disorders · Phase NA · Nov 2025
- Anemia · Phase PHASE2 · Jul 2025
- Early Stage Lung Cancer (I and II) · Phase PHASE2 · Mar 2025
See all terminations from VA Office of Research and Development
A PHASE2 clinical study on PTSD, this trial is terminated or withdrawn. The trial is conducted by VA Office of Research and Development and has accumulated 9 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Apr 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Nov 2022 — Apr 2023 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Dec 2021 — Nov 2022 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
▶ Show 4 earlier versions
-
Jun 2021 — Dec 2021 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2021 — Jun 2021 [monthly]
Not Yet Recruiting PHASE2
-
Jul 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2020 — Jul 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- VA Office of Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .